COVID-19 Vaccines: Can US FDA Complete Assessment In Less Than Six Weeks?

With strong data from Moderna and Pfizer, the projection for an EUA by the end of 2020 still may hold despite holidays and other obstacles to completing the necessary work.

Sand running through the bulbs of an hourglass measuring the passing time in a countdown to a deadline, on a dark background with copy space.
Experts continue to project a coronavirus vaccine EUA will be granted by the end of 2020. • Source: Shutterstock

A 2020 emergency use authorization for a coronavirus vaccine still remains possible with interim data now available, but with less than two months left in the year, the pressure on US Food and Drug Administration staff to meet the expectation is growing.

Moderna, Inc. became the second vaccine sponsor to report interim results with its 16 November announcement that the independent...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Vaccines

More from Pink Sheet